Pharmacy Meeting Notices
This page contains the meeting notices for the Pharmaceutical and Therapeutics Committee, and the Drug Utilization Review Board. Please check here periodically for the latest meeting dates, times, and locations.
Drug Utilization Review (DUR) Board and Pharmaceutical and Therapeutics (P&T) Committee Meetings
The next meeting of the DUR Board is scheduled for:
Date: Thursday, March 13, 2025
Time: 1:30 – 4:30 p.m. Eastern Time
Location: Zoom Webinar Only
Please click the link below to join the webinar:
https://primetherapeutics.zoom.us/j/83897124401
Phone one-tap:
+13092053325,,83897124401# US
+13126266799,,83897124401# US (Chicago)
Join via audio:
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 346 248 7799 US (Houston)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
+1 564 217 2000 US
+1 646 558 8656 US (New York)
+1 646 931 3860 US
+1 669 444 9171 US
+1 669 900 9128 US (San Jose)
+1 689 278 1000 US
+1 719 359 4580 US
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 301 715 8592 US (Washington DC)
+1 305 224 1968 US
Webinar ID: 838 9712 4401
International numbers available: https://primetherapeutics.zoom.us/u/kdV0nGBQAM
Thank You!
March 2025 DUR Agenda
[
89.6 kB
]
NOTE:
Public testimony requests for the March 13, 2025, DUR Board meeting will be OPEN from 6:00AM ET on Monday, February 3, 2025, through Friday, February 14, 2025, at 5:00 PM ET.
Those selected for public testimony must be present during the Webinar to speak. You will be notified of your selection status by 5:00PM ET on Monday, February 17, 2025.
All interested parties can request a 2-minute speaker slot by completing the online form at: https://forms.office.com/g/CV2rHFuRFn
Pharmaceutical and Therapeutics Committee
The next meeting of the P&T Committee is scheduled for:
Date: Friday, March 14, 2025
Time: 8:30 a.m. - 12:30 p.m. Eastern Time
Location: Zoom Webinar Only
Please click the link below to join the webinar:
https://primetherapeutics.zoom.us/j/81373738996
Phone one-tap:
+13092053325,,81373738996# US
+13126266799,,81373738996# US (Chicago)
Join via audio:
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
+1 646 931 3860 US
+1 301 715 8592 US (Washington DC)
+1 305 224 1968 US
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
+1 564 217 2000 US
+1 669 444 9171 US
+1 669 900 9128 US (San Jose)
+1 689 278 1000 US
+1 719 359 4580 US
Webinar ID: 813 7373 8996
International numbers available: https://primetherapeutics.zoom.us/u/kl48ssu7d
Join from an H.323/SIP room system:
H.323:
144.195.19.161 (US West)
206.247.11.121 (US East)
115.114.131.7 (India Mumbai)
115.114.115.7 (India Hyderabad)
159.124.15.191 (Amsterdam Netherlands)
159.124.47.249 (Germany)
159.124.104.213 (Australia Sydney)
159.124.74.212 (Australia Melbourne)
170.114.180.219 (Singapore)
64.211.144.160 (Brazil)
159.124.132.243 (Mexico)
159.124.168.213 (Canada Toronto)
159.124.196.25 (Canada Vancouver)
170.114.194.163 (Japan Tokyo)
147.124.100.25 (Japan Osaka)
Meeting ID: 813 7373 8996
SIP: [email protected]
March 2025 P&T Agenda
[
380.3 kB
]
NOTE:
Public testimony requests for the March 14, 2025, Pharmaceutical and Therapeutics committee will be OPEN from 6:00AM ET on Monday, February 3, 2025, through Friday, February 14, 2025, at 5:00 PM ET.
Those selected for public testimony must be present during the Webinar to speak. You will be notified of your selection status by 5:00PM ET on Monday, February 17, 2025.
All interested parties can request a 2-minute speaker slot by completing the online form at: https://forms.office.com/g/NeAk548t1f
